<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: We sought to determine the predictive value of magnetic resonance imaging measures of <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> (white matter hyperintensities [WMHs], lacunes, microbleeds, and <z:mpath ids='MPATH_124'>infarcts</z:mpath>) compared with <z:mpath ids='MPATH_127'>atrophy</z:mpath> on the progression of mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> to <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We included 152 consecutive patients with mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Baseline magnetic resonance imaging was used to determine the presence of medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> and <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> (presence of lacunes, microbleeds, and <z:mpath ids='MPATH_124'>infarcts</z:mpath> was determined, and WMHs were rated on a semiquantitative scale) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients were followed up for 2+/-1 years </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Seventy-two (47%) patients progressed to <z:hpo ids='HP_0000726'>dementia</z:hpo> during follow-up </plain></SENT>
<SENT sid="5" pm="."><plain>Of these, 56 (37%) patients were diagnosed with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, and 16 (10%) patients were diagnosed with a non-Alzheimer <z:hpo ids='HP_0000726'>dementia</z:hpo> (including vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, <z:e sem="disease" ids="C0751072" disease_type="Mental or Behavioral Dysfunction" abbrv="FTLD">frontotemporal lobar degeneration</z:e>, and Parkinson <z:hpo ids='HP_0000726'>dementia</z:hpo>) </plain></SENT>
<SENT sid="6" pm="."><plain>Converters were older and had a lower Mini-Mental State Examination score at baseline </plain></SENT>
<SENT sid="7" pm="."><plain>On baseline magnetic resonance imaging, patients who progressed to a non-Alzheimer <z:hpo ids='HP_0000726'>dementia</z:hpo> showed more severe WMHs and had a higher prevalence of lacunes in the basal ganglia and microbleeds compared with nonconverters </plain></SENT>
<SENT sid="8" pm="."><plain>Cox proportional-hazard models showed that, adjusted for age and sex, baseline medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> (hazard ratio=2.9; 95% CI, 1.7 to 5.3), but not <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, was associated with progression to <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>By contrast, deep WMHs (hazard ratio=5.7; 95% CI, 1.2 to 26.7) and periventricular hyperintensities (hazard ratio=6.5; 95% CI, 1.4 to 29.8) predicted progression to non-Alzheimer <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, microbleeds (hazard ratio=2.6; 95% CI, 0.9 to 7.5) yielded a &gt;2-fold increased, though nonsignificant, risk of non-Alzheimer <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: Medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> and markers of cerebrovascular disease predict the development of different types of <z:hpo ids='HP_0000726'>dementia</z:hpo> in mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> patients </plain></SENT>
</text></document>